The latest example: Reams of wrongheaded hedge-fund short plays off the Ebola crisis.
We will buy 300 shares of Kinder Morgan.
We see upside in its offer for a rival dollar store.
Companies with smaller visions but bigger buybacks rule right now.
We will watch for weakness to add shares.
There's a powerful collection of 'what's working.'
We'll continue to build out our position in Unilever.
The Improve-It trial has met its primary endpoint, thus removing an overhang on the stock.
Even the best of short ideas can kill you in this market.
Catch up on Jim Cramer's thinking over the last week about retail stocks, which might be getting their groove back, and the economic impact of Obama's statements.